PRG4
PRG4 (proteoglycan 4), also known as lubricin, JCAP, SZP, MSF, HAPO and CACP, is a large secreted proteoglycan made by chondrocytes at the articular cartilage surface and by some synovial lining cells. It acts as a boundary lubricant in the joint. Browse Assay Genie's current range of PRG4 research reagents below, or read on for the biology behind the target.
PRG4 is a large proteoglycan synthesised by chondrocytes located at the surface of articular cartilage and by some synovial lining cells. The protein carries both chondroitin sulfate and keratan sulfate glycosaminoglycans. It functions as a boundary lubricant at the cartilage surface and contributes to the elastic absorption and energy dissipation of synovial fluid, which makes it a central molecule in studies of joint lubrication and cartilage biology.
The PRG4 gene encodes a secreted protein, and alternative splicing results in multiple transcript variants. In UniProt, isoform F is annotated as playing a role as a growth factor acting on the primitive cells of both haematopoietic and endothelial cell lineages. This reflects one of the historical names of the protein, megakaryocyte stimulating factor (MSF). Researchers working with the PRG4 protein therefore encounter it in both musculoskeletal and haematopoietic contexts.
The gene's other names record how it was discovered and characterised: articular superficial zone protein (SZP), megakaryocyte stimulating factor (MSF) and the disease-based name camptodactyly, arthropathy, coxa vara, pericarditis syndrome (CACP). Mutations in the PRG4 gene result in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. The mouse ortholog is Prg4, and measuring PRG4 by ELISA kit or detecting it with a PRG4 antibody is a common way to study its expression in synovial and cartilage research.
PRG4 acts as a boundary lubricant at the cartilage surface, so it is studied in models of synovial joint function.
PRG4 is synthesised by chondrocytes at the articular surface, making it a marker of surface-zone cartilage cells.
PRG4 contributes to elastic absorption and energy dissipation of synovial fluid, relevant to joint load-bearing studies.
Mutations in PRG4 cause camptodactyly-arthropathy-coxa vara-pericarditis syndrome, supporting research into inherited arthropathy.
PRG4 is a secreted proteoglycan bearing chondroitin sulfate and keratan sulfate chains. It works as a boundary lubricant at the cartilage surface and contributes to the elastic absorption and energy dissipation of synovial fluid. Isoform F is also annotated as a growth factor for primitive haematopoietic and endothelial cells.
PRG4 is also called JCAP, SZP, MSF, HAPO, CACP, bG174L6.2 and FLJ32635. Earlier names include megakaryocyte stimulating factor and articular superficial zone protein. Alternative splicing produces multiple transcript variants, so check the datasheet of any product for its validated reactivity and isoform coverage.
Yes. Mutations in the PRG4 gene result in camptodactyly-arthropathy-coxa vara-pericarditis syndrome, which gave the gene its CACP alias. The mouse ortholog is Prg4, which allows related questions to be studied in rodent models; check the datasheet of any product for its validated reactivity.
Other proteoglycan family members with research reagents at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92954; product specifications from Assay Genie datasheets.